Effects of an alternative reinforcer on intravenous heroin self- administration by humans

European Journal of Pharmacology

Volumn 345, Issue 1, 1998, Pages 13-26

  Comer, Sandra D ^a   Collins, Eric D ^a   Wilson, Scott T ^a   Donovan, Michael R ^a   Foltin, Richard W ^a   Fischman, Marian W ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

(Human); Heroin; Opioid; Performance; Progressive ratio; Self administration; Subjective effect

Indexed keywords

CLONIDINE; DIAMORPHINE; DOCUSATE SODIUM; IBUPROFEN; IRON; KETOROLAC TROMETAMOL; MAGNESIUM HYDROXIDE; MORPHINE; MULTIVITAMIN; MYLANTA; OXAZEPAM; PARACETAMOL; PLACEBO; TRAZODONE;

ADULT; ARTICLE; BLOOD OXYGEN TENSION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DOSE RESPONSE; DRUG POTENCY; DRUG SELF ADMINISTRATION; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONEY; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUPIL; REINFORCEMENT; TASK PERFORMANCE; WITHDRAWAL SYNDROME;

ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NARCOTICS; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE ABUSE, INTRAVENOUS; TOKEN ECONOMY;

EID: 0032510516     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01572-0     Document Type: Article

References (59)

1. Altman J.L., Meyer R.E., Mirin S.M., McNamee H.B. Opiate antagonists and the modification of heroin self-administration behavior in man: An experimental study. Int. J. Addictions. 11:1976;485-499.
2. Bertalmio A.J., Medzihradsky F., Winger G., Woods J.H. Differential influence of N-dealkylation on the stimulus properties of some opioid agonists. J. Pharmacol. Exp. Ther. 261:1992;278-284.
3. Carroll, M.E., 1996. Reducing drug abuse by enriching the environment with alternative nondrug reinforcers. In: Green, L., Kagel, J.H. (Eds.), Advances in Behavioral Economics, vol. 3: Substance Use and Abuse. Albex Publishing Corporation, Norwood, NJ, pp. 37-68.
4. Comer S.D., Lac S.T., Curtis L.K., Carroll M.E. Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats. J. Pharmacol. Exp. Ther. 267:1993;1470-1477.
5. De Wit H., Chutuape M.A. Increased ethanol choice in social drinkers following ethanol preload. Behav. Pharmacol. 4:1993;29-36.
6. De Wit H., Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology. 75:1981;134-143.
7. De Wit H., Stewart J. Reinstatement of heroin-reinforced responding in the rat. Psychopharmacology. 79:1983;29-31.
8. Elmer G.I., Pieper J.O., Goldberg S.R., George F.R. Opioid operant self-administration, analgesia, stimulation and respiratory depression in μ-deficient mice. Psychopharmacology. 117:1995;23-31.
9. Fischman, M.W., Foltin, R.W., 1992. Self-administration of cocaine by humans: A laboratory perspective. In: Cocaine: Scientific and Social Dimensions. Ciba Foundation Symposium No. 166. Wiley and Sons, New York, pp. 165-180.
10. Fischman M.W., Schuster C.R. Cocaine self-administration in humans. Fed. Proc. 41:1982;241-246.
11. Foltin R.W., Fischman M.W. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J. Pharmacol. Exp. Ther. 261:1992;623-632.
12. Foltin R.W., Fischman M.W. Interaction of buprenorphine with cocaine-morphine combinations. Exp. Clin. Psychopharmacol. 3:1995;261-269.
13. Fraser H.F., van Horn G.D., Martin W.R., Wolbach A.B., Isbell H. Methods for evaluating addiction liability. (A) 'Attitude' of opiate addicts toward opiate-like drugs, (B) a short-term 'direct' addiction test. J. Pharmacol. Exp. Ther. 133:1961;371-387.
14. Fraser H.F., Kay D.C., Gorodetzky C.W., Yeh S.Y., Dewey W.L. Evidence for the importance of n-dealkylation in opioid pharmacology. Drug Alcohol Depend. 3:1978;1-22.
15. Fraser H.F., Kay D.C., Yeh S.Y., Gorodetzky C.W. Possible effects of normetabolites on the subjective and reinforcing characteristics of opioids in animals and man. Drug Alcohol Depend. 3:1978;301-318.
16. Freedman R.R., Czertko G. A comparison of thrice weekly LAAM and daily methadone in employed heroin addicts. Drug Alcohol Depend. 8:1981;215-222.
17. Handelsman L., Cochrane K.J., Aronson M.J., Ness R., Rubinstein K.J., Kanof P.D. Two new rating scales for opiate withdrawal. Am. J. Drug Alcohol Abuse. 13:1987;293-308.
18. Harrigan S.E., Downs D.A. Self-administration of heroin, acetylmethadol, morphine, and methadone in rhesus monkeys. Life Sci. 22:1978;619-624.
19. Higgins S.T., Bickel W.K., Hughes J.R. Influence of an alternative reinforcer on human cocaine self-administration. Life Sci. 55:1994;179-187.
20. Jaffe J.H., Schuster C.R., Smith B.B., Blachley P.H. Comparison of acetylmethadol and methadone in the treatment of long-term heroin users. J. Am. Med. Assoc. 211:1970;1834-1836.
21. Jasinski D.R., Preston K.L. Comparison of intravenously administered methadone, morphine and heroin. Drug Alcohol Depend. 17:1986;301-310.
22. Jenkins A.J., Keenan R.M., Henningfield J.E., Cone E.J. Pharmacokinetics and pharmacodynamics of smoked heroin. J. Anal. Toxicol. 18:1994;317-330.
23. Johanson, C.E., Schuster, C.R., 1981. Animal models of drug self-administration. In: Advances in Substance Abuse, vol. 2. JAI Press, pp. 219-297.
24. Judson B.A., Carney T.M., Goldstein A. Naltrexone treatment of heroin addiction: Efficacy and safety in a double-blind dosage comparison. Drug Alcohol Depend. 7:1981;325-346.
25. Kelly T.H., Foltin R.W., Emurian C.S., Fischman M.W. Performance-based testing for drugs of abuse: Dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. J. Anal. Toxicol. 17:1993;264-272.
26. Kerr B., Hill H., Coda B., Calogero M., Chapman C.R., Hunt E., Buffington V., Mackie A. Concentration-related effects of morphine on cognition and motor control in human subjects. Neuropsychopharmacology. 5:1991;157-166.
27. Kleber, H.D., Slobetz, F., Mezritz, M., 1980. Medical evaluation of long-term methadone-maintained clients. Services Research Monograph Series, National Institute on Drug Abuse.
28. Kreek M.J. Medical safety and side effects of methadone in tolerant individuals. J. Am. Med. Assoc. 223:1973;665-668.
29. Kuribara H. Modification of morphine sensitization by opioid and dopamine receptor antagonists: Evaluation by studying ambulation in mice. Eur. J. Pharmacol. 275:1995;251-258.
30. Lamb R.J., Preston K.L., Schindler C.W., Meisch R.A., Davis F., Katz J.L., Henningfield J.E., Goldberg S.R. The reinforcing and subjective effects of morphine in post-addicts: A dose-response study. J. Pharmacol. Exp. Ther. 259:1991;1165-1173.
31. Martin W.R., Fraser H.F. A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J. Pharmacol. Exp. Ther. 133:1961;388-399.
32. Martin W.R., Jasinski D.R., Haertzen C.A., Kay D.C., Jones B.E., Mansky P.A., Carpenter R.W. Methadone: A reevaluation. Arch. Gen. Psychiatry. 28:1973;286-295.
33. Martin W.R., Jasinski D.R., Mansky P.A. Naltrexone, an antagonist for the treatment of heroin dependence. Arch. Gen. Psychiatry. 28:1973;784-791.
34. McLeod D.R., Griffiths R.R., Bigelow G.E., Yingling J. An automated version of the digit symbol substitution test (DSST). Behav. Res. Method Instrum. 14:1982;463-466.
35. Mello N.K., Mendelson J.H. Buprenorphine suppresses heroin use by heroin addicts. Science. 207:1980;657-659.
36. Mello N.K., Bree M.P., Mendelson J.H. Comparison of buprenorphine and methadone effects on opiate self-administration in primates. J. Pharmacol. Exp. Ther. 225:1983;378-386.
37. Mello N.K., Bree M.P., Mendelson J.H. Buprenorphine, heroin, and methadone: Comparison of relative reinforcing properties. NIDA Res. Monogr. 49:1984;172-178.
38. Mendelson, J.H., Mello, N.K., 1978. Heroin self-administration: An operant analysis. NIDA Res. Monogr., 128-148.
39. Meyer, R.E., Mirin, S.M., 1979. The Heroin Stimulus: Implications for a Theory of Addiction. Plenum Publishing Corporation, New York.
40. Miller T.P., Taylor J.L., Tinklenberg J.R. A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics. Neuropsychobiology. 19:1988;90-96.
41. Moerschbaecher J.M., Thompson D.M., Winsauer P.J. Effects of heroin, methadone, LAAM and cyclazocine on acquisition and performance of response sequences in monkeys. Pharmacol. Biochem. Behav. 19:1983;701-710.
42. O'Brien C.P. Experimental analysis of conditioning factors in human narcotic addiction. Pharmacol. Rev. 27:1976;533-543.
43. Pakarinen E.D., Woods J.H., Moerschbaecher J.M. Repeated acquisition of behavioral chains in squirrel monkeys: Comparison of a mu, kappa and delta opioid agonist. J. Pharmacol. Exp. Ther. 272:1995;552-559.
44. Pickworth W.B., Johnson R.E., Holicky B.A., Cone E.J. Subjective and physiologic effects of intravenous buprenorphine in humans. Clin. Pharmacol. Ther. 53:1993;570-576.
45. Preston K.L., Bigelow G.E., Bickel W.K., Liebson I.A. Drug discrimination in human postaddicts: Agonist-antagonist opioids. J. Pharmacol. Exp. Ther. 250:1989;184-196.
46. Preston K.L., Liebson I.A., Bigelow G.E. Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination. J. Pharmacol. Exp. Ther. 261:1992;62-71.
47. Reisine, T., Pasternak, G., 1996. Opioid analgesics and antagonists. In: Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Gilman, A.G. (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. McGraw-Hill Health Professionals Division, New York, pp. 521-555.
48. Senay E.C., Dorus W., Renault P.F. Methadyl acetate and methadone: An open comparison. J. Am. Med. Assoc. 237:1977;138-142.
49. Spiga R., Grabowski J., Silverman P.B., Meisch R.A. Human methadone self-administration: Effects of dose and ratio requirement. Behav. Pharmacol. 7:1996;130-137.
50. Stewart J., Wise R.A. Reinstatement of heroin self-administration habits: Morphine prompts and naltrexone discourages renewed responding after extinction. Psychopharmacology. 108:1992;79-84.
51. Stitzer M.L., Bigelow G.E., Liebson I. Reducing drug use among methadone maintenance clients: Contingent reinforcement for morphine-free urines. Addict. Behav. 5:1980;333-340.
52. Stitzer M.L., McCaul M.E., Bigelow G.E., Liebson I.A. Oral methadone self-administration: Effects of dose and alternative reinforcers. Clin. Pharmacol. Ther. 34:1983;29-35.
53. Strain E.C., Preston K.L., Liebson I.A., Bigelow G.E. Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers. J. Pharmacol. Exp. Ther. 261:1992;985-993.
54. Vuchinich R.E., Tucker J.A. Behavioral theories of choice as a framework for studying drinking behavior. J. Abn. Psychol. 92:1983;408-416.
55. Wang R.I.H., Wiesen R.L., Lamid S., Roh B.L. Rating the presence and severity of opiate dependence. Clin. Pharmacol. Ther. 16:1974;653-658.
56. Wesnes K., Warburton D.M. Effects of smoking on rapid information processing performance. Neuropsychobiology. 9:1983;223-229.
57. Worley C.M., Valadez A., Schenk S. Reinstatement of extinguished cocaine-taking behavior by cocaine and caffeine. Pharmacol. Biochem. Behav. 48:1994;217-221.
58. Zacny J.P. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp. Clin. Psychopharmacol. 3:1995;432-466.
59. Zacny J.P., Lichtor J.L., Flemming D., Coalson D.W., Thompson W.K. A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers. J. Pharmacol. Exp. Ther. 268:1994;1-9.